Physician profile
Daniel Allendorf
NPI 1073716163
$2,398.15
in general payments reported to CMS, 2019-2025
24 companies · $70.38 in 2025
The $70.38 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $430 · 2021: $24.72 · 2022: $26.99 · 2024: $26.98 · 2025: $70.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.38 · Education: $26.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.38 |
| Education | $26.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $302.44 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $255.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $220.56 | 2019-2020 | |
| Celgene Corporation | $210.29 | 2019-2025 | Reblozyl |
| Genentech USA, INC. | $196.81 | 2019-2020 | |
| Amgen INC. | $184.02 | 2019-2020 | |
| Incyte Corporation | $140.67 | 2019-2025 | Monjuvi |
| Tesaro, INC. | $115.88 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $99.63 | 2019-2020 | |
| Genzyme Corporation | $96.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $94.61 | 2019-2020 | |
| Seagen INC. | $89.55 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $74.27 | 2019-2020 | |
| Abbvie INC. | $52.59 | 2022-2025 | |
| Gilead Sciences, INC. | $44.80 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $42.71 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $42.57 | 2019 | |
| Daiichi Sankyo INC. | $42.32 | 2019-2024 | Enhertu |
| Rigel Pharmaceuticals, INC. | $19.17 | 2019 | |
| Glaxosmithkline, LLC. | $18.03 | 2020 | |
| Kite Pharma, INC. | $15.63 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $15.34 | 2019 | |
| Advanced Accelerator Applications | $12.07 | 2019 | |
| Lilly USA, LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Allendorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.